Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. [electronic resource]
- Circulation Aug 2006
- 912-20 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1524-4539
10.1161/CIRCULATIONAHA.106.634709 doi
Amino Acid Sequence Animals Biotinylation Caveolin 1--administration & dosage Cell Membrane Permeability Disease Models, Animal Hypertension, Pulmonary--chemically induced Hypertrophy, Right Ventricular--chemically induced Male Molecular Sequence Data Monocrotaline--toxicity Peptide Fragments--therapeutic use Rats Rats, Sprague-Dawley